Kalbe Farma and Kimia Farma to open raw materials plants in Indonesia
05-Jan-16, PR Newswire
Vidjongtius, director of Indonesia's largest pharmaceutical company, Kalbe Farma, stated that raw material import is a big challenge for the local pharmacy industry. As a response, he declared, Kalbe Farma is currently constructing a biopharmacy raw material manufacturing plant in Cikarang, West Java, scheduled to commercially commence operations in late 2017 or 2018.
%20Kalbe%20Farma_Kimia%20Farma.jpg "Kalbe Farma and Kimia Farma to open raw materials plants in Indonesia (c) Kalbe Farma Kimia Farma")
Image: Kalbe Farma and Kimia Farma
State-controlled pharmaceutical company Kimia Farma also announced recently that it would start constructing a Rp 100 billion raw materials plant in Cikarang, West Java, in 2016.
Meanwhile, in a bid to encourage the industry, the Investment Coordinating Board (BKPM) gauged a plan to allow foreign investors to hold more shares in pharmacy companies, from currently a maximum of 85 percent, to 100 percent.